Other newly identified gene polymorphisms apparently involved in the NAFLD–CAD relationship are represented by: adiponectin rs266729 [118], adiponectin-encoding gene (ADIPOQ), apolipoprotein C3 (APOC3), leptin receptor (LEPR), peroxisome proliferator activated receptors (PPAR), tumor necrosis factor-alpha (TNF-α), microsomal triglyceride transfer protein (MTTP), and manganese superoxide dismutase (MnSOD) [105,119]. The gene discussed is APOC3; the disease is metabolic dysfunction-associated steatotic liver disease.